✦ LIBER ✦

CV5 PHARMACOECONOMIC EVALUATION OF SIMVASTATIN VERSUS “NO TREATMENT” IN PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART DISEASE (CHD) IN POLAND

✍ Scribed by A Plich; KJ Filipiak; J Splawinski; W Gumulka

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CEB3: COST-EFFECTIVENESS OF PREVENTION O

✍ J Kuzniar; E Orlewska; T Hermanowski; W Romanczuk; J Splawinski 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Antioxidant effects of simvastatin in pr

✍ A. Tavridou; A. Efthimiadis; I. Efthimiadis; H. Paschalidou 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 94 KB

W05.161 The effect of simvastatin on Ox-

✍ Tavridou, A.; Efthimiadis, A.; Efthimiadis, I.; Tzanakari, A.; Tsitlakidou, M.; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB

PCV79 Economic Evaluation of Rosuvastati

✍ V. Fragoulakis; G. Kourlaba; N. Maniadakis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

The association between socioeconomic st

✍ Shaoli Niu; Dong Zhao; Junren Zhu; Jun Liu; Qun Liu; Jing Liu; Wei Wang; Sidney 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 329 KB

CV2: COST-EFFECTIVENESS OF TREATING HIGH

✍ KW Lauterbach; E Hunsche; U Klewer 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB